Repository logo
 
Publication

Melanoma da Coroideia

dc.contributor.authorCoutinho, I
dc.contributor.authorTeixeira, T
dc.contributor.authorSimões, C
dc.contributor.authorLopes, C
dc.contributor.authorBorrego, M
dc.contributor.authorFernandes, J
dc.contributor.authorCabral, J
dc.contributor.authorPrieto, I
dc.contributor.authorProença, R
dc.date.accessioned2018-11-06T16:42:35Z
dc.date.available2018-11-06T16:42:35Z
dc.date.issued2017
dc.description.abstractChoroidal melanoma is the most common primary intraocular malignant tumor in adults. None of the different treatments available offers advantages of survival, resorting more and more to conservative treatments such as brachytherapy, which has been available in Portugal since 2013. In this article we review the clinical characteristics, risk factors, diagnosis, complementary exams and therapeutic options in choroidal melanoma.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationActa Med Port. 2017 Aug 31;30(7-8):573-577pt_PT
dc.identifier.doi10.20344/amp.8535pt_PT
dc.identifier.issn1646–0758
dc.identifier.urihttp://hdl.handle.net/10400.10/2046
dc.language.isoporpt_PT
dc.peerreviewedyespt_PT
dc.publisherOrdem dos Médicospt_PT
dc.relation.publisherversionfile://u_share/users/arminda.m.sustelo/Desktop/PC/Acta%20Med%20Port.%202017%20Aug.pdfpt_PT
dc.subjectMelanomapt_PT
dc.subjectNeoplasias da coróidept_PT
dc.titleMelanoma da Coroideiapt_PT
dc.title.alternativeChoroidal Melanomapt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceLisboapt_PT
oaire.citation.endPage577pt_PT
oaire.citation.startPage573pt_PT
oaire.citation.titleActa Médica Portuguesapt_PT
oaire.citation.volume30pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Acta Med Port. 2017 Aug.pdf
Size:
1.73 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: